The CLLAF Score predicts AF risk in CLL patients on BTKi therapy, including second-generation BTKis, using easily obtainable parameters. Ibrutinib is associated with a higher AF risk compared to ...
Safety and efficacy of bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients (pts) with relapsed or refractory myelofibrosis (r/r-MF) and other advanced myeloid neoplasms: A phase (Ph) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback